A detailed history of Trust Point Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Trust Point Inc. holds 1,935 shares of NBIX stock, worth $241,875. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,935
Previous 1,586 22.01%
Holding current value
$241,875
Previous $218 Million 2.11%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$114.58 - $153.15 $39,988 - $53,449
349 Added 22.01%
1,935 $223 Million
Q2 2024

Jul 24, 2024

BUY
$130.86 - $143.19 $207,543 - $227,099
1,586 New
1,586 $218 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.